SynthesisMedicine2018

Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis.

Jiansong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.